BRPI0719359A2 - Inibidores de proteína tirosina fosfatase para a promoção de hipertrofia cardíaca fisiológica - Google Patents
Inibidores de proteína tirosina fosfatase para a promoção de hipertrofia cardíaca fisiológicaInfo
- Publication number
- BRPI0719359A2 BRPI0719359A2 BRPI0719359-9A2A BRPI0719359A BRPI0719359A2 BR PI0719359 A2 BRPI0719359 A2 BR PI0719359A2 BR PI0719359 A BRPI0719359 A BR PI0719359A BR PI0719359 A2 BRPI0719359 A2 BR PI0719359A2
- Authority
- BR
- Brazil
- Prior art keywords
- promotion
- protein tyrosine
- tyrosine phosphatase
- phosphatase inhibitors
- heart hypertrophy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87232606P | 2006-12-01 | 2006-12-01 | |
PCT/US2007/086070 WO2008070552A2 (en) | 2006-12-01 | 2007-11-30 | Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0719359A2 true BRPI0719359A2 (pt) | 2014-10-07 |
Family
ID=39232939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0719359-9A2A BRPI0719359A2 (pt) | 2006-12-01 | 2007-11-30 | Inibidores de proteína tirosina fosfatase para a promoção de hipertrofia cardíaca fisiológica |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100035860A1 (pt) |
EP (1) | EP2089026A2 (pt) |
JP (1) | JP2010511629A (pt) |
KR (1) | KR20090087019A (pt) |
CN (1) | CN101547694A (pt) |
AU (1) | AU2007329512A1 (pt) |
BR (1) | BRPI0719359A2 (pt) |
CA (1) | CA2670491A1 (pt) |
MX (1) | MX2009005550A (pt) |
WO (1) | WO2008070552A2 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0619547A2 (pt) * | 2005-12-08 | 2011-10-04 | Novartis Ag | 1,1,3-trioxo-1,2,5-tiadiazolidinas, composição farmacêutica e uso das mesmas |
US8119666B2 (en) * | 2005-12-08 | 2012-02-21 | Novartis Ag | 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (PTPase) |
MA41562B1 (fr) | 2015-06-03 | 2019-05-31 | Bristol Myers Squibb Co | Agonistes d'apj 4-hydroxy-3-(heteroaryl)pyridine-2-one a utiliser dans le traitement de troubles cardio-vasculaires |
EP3393497A1 (en) * | 2015-12-23 | 2018-10-31 | Sanofi-Aventis Deutschland GmbH | Cardiac metabolic effect of lantus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ237463A (en) * | 1990-03-23 | 1993-07-27 | Merck & Co Inc | Protein phosphatase inhibitor-1 (ppi-1), dna encoding it, vectors and host cells |
GB0225986D0 (en) * | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
-
2007
- 2007-11-30 EP EP07864981A patent/EP2089026A2/en not_active Withdrawn
- 2007-11-30 CA CA002670491A patent/CA2670491A1/en not_active Abandoned
- 2007-11-30 JP JP2009539510A patent/JP2010511629A/ja active Pending
- 2007-11-30 CN CNA200780044480XA patent/CN101547694A/zh active Pending
- 2007-11-30 US US12/515,519 patent/US20100035860A1/en not_active Abandoned
- 2007-11-30 KR KR1020097011037A patent/KR20090087019A/ko not_active Application Discontinuation
- 2007-11-30 AU AU2007329512A patent/AU2007329512A1/en not_active Abandoned
- 2007-11-30 MX MX2009005550A patent/MX2009005550A/es not_active Application Discontinuation
- 2007-11-30 BR BRPI0719359-9A2A patent/BRPI0719359A2/pt not_active Application Discontinuation
- 2007-11-30 WO PCT/US2007/086070 patent/WO2008070552A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2007329512A1 (en) | 2008-06-12 |
JP2010511629A (ja) | 2010-04-15 |
CN101547694A (zh) | 2009-09-30 |
EP2089026A2 (en) | 2009-08-19 |
MX2009005550A (es) | 2009-06-05 |
WO2008070552A3 (en) | 2008-07-24 |
CA2670491A1 (en) | 2008-06-12 |
US20100035860A1 (en) | 2010-02-11 |
KR20090087019A (ko) | 2009-08-14 |
WO2008070552A2 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2016029I1 (el) | Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9) | |
CY2014011I2 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
BRPI0722082A2 (pt) | Ligantes para imagiologia da inervação cardíaca | |
DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
ATE522624T1 (de) | Identifizierung von krankheitserregern | |
BRPI0812360A2 (pt) | Compostos moduladores de quinase heterocíclica e método de modulação da atividade de uma proteína tirosina quinase | |
BRPI0816784A2 (pt) | Fatores neuro-endócrinos para o tratamento de doenças degenerativas | |
DE502007001122D1 (de) | Humeruskomponente | |
DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
DK2041088T3 (da) | Glycintransporter-1 inhibitorer | |
BRPI0719359A2 (pt) | Inibidores de proteína tirosina fosfatase para a promoção de hipertrofia cardíaca fisiológica | |
FR2904210B1 (fr) | Trocart endorectal | |
NO20084739L (no) | Substituerte 3-cyanopyridiner som protein kinase inhibitorer | |
ITMI20060489A1 (it) | Procedimento per la preparazione di 1-beono-3-trifluorometossibenzene | |
FR2897236B1 (fr) | Dessert | |
ATE434945T1 (de) | Gesundes nahrungsmittel | |
UA13363S (uk) | Комплект етикеток | |
UA12818S (uk) | Комплект етикеток | |
UA12815S (uk) | Комплект етикеток | |
UA12817S (uk) | Комплект етикеток | |
UA12499S (uk) | Комплект етикеток | |
UA12819S (uk) | Комплект етикеток | |
UA12988S (uk) | Комплект етикеток | |
UA13740S (uk) | Комплект етикеток |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |